Received Apr 15, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMRV | MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) | MERCK & CO. INC. | UNK | — | OT |
No additional AE; inadvertent administration of PROQUAD to an adult patient on 11APR2025 who was supposed to receive a dose of MMR-II; This spontaneous report was received from a registered nurse and refers to an adult female patient. The patient's medical history, concurrent conditions and concomitant therapies were not reported. Historical drug included Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (MMR-II) in 1993. The reporter reported inadvertent administration of Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD) for prophylaxis to an adult patient on 11-APR-2025 who was supposed to receive a dose of Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (MMR-II) for prophylaxis. Both suspect vaccines were reconstituted with sterile diluent (MERCK STERILE DILUENT). No additional adverse event. The dose, strength, route, lot number and expiration date were not reported for suspect products. Lot number is being requested and will be submitted if received.
Sterile Diluent